Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

555 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study.
Ozaki Y, Aoyama Y, Masuda J, Inagaki L, Kawai S, Shibayama T, Maeda T, Kurata M, Yoshida K, Saeki S, Hosonaga M, Fukada I, Hara F, Kobayashi T, Kobayashi K, Miyake S, Takano T, Ueno T, Ohno S. Ozaki Y, et al. Among authors: saeki s. BMC Cancer. 2022 Jan 4;22(1):36. doi: 10.1186/s12885-021-09128-1. BMC Cancer. 2022. PMID: 34983437 Free PMC article.
Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin.
Saeki S, Kumegawa K, Takahashi Y, Yang L, Osako T, Yasen M, Otsuji K, Miyata K, Yamakawa K, Suzuka J, Sakimoto Y, Ozaki Y, Takano T, Sano T, Noda T, Ohno S, Yao R, Ueno T, Maruyama R. Saeki S, et al. Breast Cancer Res. 2023 Feb 21;25(1):21. doi: 10.1186/s13058-023-01617-4. Breast Cancer Res. 2023. PMID: 36810117 Free PMC article.
Correction: Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility.
Kumegawa K, Saeki S, Takahashi Y, Yang L, Osako T, Nakadai T, Amino S, Maeda T, Takahata C, Mori S, Noda T, Ohno S, Ueno T, Maruyama R. Kumegawa K, et al. Among authors: saeki s. Br J Cancer. 2023 Mar;128(7):1400-1404. doi: 10.1038/s41416-023-02206-0. Br J Cancer. 2023. PMID: 36914723 Free PMC article. No abstract available.
Correction: Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives.
Saeki S, Iwatani T, Kitano A, Sakurai N, Tanabe Y, Yamauchi C, Igarashi A, Kajimoto Y, Kuba S, Hara F, Sagara Y, Ohno S; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society. Saeki S, et al. Breast Cancer. 2023 Sep;30(5):831. doi: 10.1007/s12282-023-01479-w. Breast Cancer. 2023. PMID: 37395979 Free PMC article. No abstract available.
Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives.
Saeki S, Iwatani T, Kitano A, Sakurai N, Tanabe Y, Yamauchi C, Igarashi A, Kajimoto Y, Kuba S, Hara F, Sagara Y, Ohno S; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society. Saeki S, et al. Breast Cancer. 2023 Sep;30(5):820-830. doi: 10.1007/s12282-023-01476-z. Epub 2023 Jun 13. Breast Cancer. 2023. PMID: 37310584 Free PMC article.
555 results